Upstream Bio (UPB) Change in Acquisitions & Divestments (2023 - 2026)

Upstream Bio's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $56.8 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 7.87% year-over-year to $56.8 million in Q1 2026; TTM through Mar 2026 was $296.7 million, a 20.1% increase from a year earlier, with the FY2025 full-year figure at $292.6 million, up 26.3% from the prior year.
• Change in Acquisitions & Divestments slipped to $56.8 million in Q1 2026 per UPB's latest filing, from $97.3 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $97.3 million in Q4 2025 and bottomed at $29.6 million in Q4 2023.
• The 4-year median for Change in Acquisitions & Divestments is $63.4 million (2025), against an average of $61.1 million.
• Across the five-year window, Change in Acquisitions & Divestments surged 185.25% in 2024 and decreased 3.23% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $29.6 million in 2023, then jumped by 185.25% to $84.3 million in 2024, then advanced by 15.39% to $97.3 million in 2025, then tumbled by 41.59% to $56.8 million in 2026.
• Per Business Quant, the three latest UPB Change in Acquisitions & Divestments figures stand at $56.8 million (Q1 2026), $97.3 million (Q4 2025), and $72.7 million (Q3 2025).